Skip to main content

MYLAN 8008 MYLAN 8008 Pill: purple white, capsule/oblong

The pill with imprint MYLAN 8008 MYLAN 8008 (Purple / White, Capsule/Oblong1) has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg and is used for Bipolar Disorder, Mania, Migraine Prevention, Seizures, and Epilepsy. It belongs to the drug class fatty acid derivative anticonvulsants and is not a controlled substance.

Images for MYLAN 8008 MYLAN 8008

Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint
MYLAN 8008 MYLAN 8008
Strength
125 mg
Color
Purple / White
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
ammonia, silicon dioxide, copovidone, croscarmellose sodium, dibutyl sebacate, FD&C Blue No. 2, lactose monohydrate, maltodextrin, mannitol, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, oleic acid, polysorbate 80, ferric oxide red, sodium hydroxide, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triacetin, triethyl citrate, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-8008 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0765 (Discontinued) UDL Laboratories Inc.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.